Alerts will be sent to your verified email
Verify EmailSANOFI
|
Sanofi India
|
Viyash Scientific
|
Procter&Gamble Healt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
1.7 % | n/a | 20.1 % |
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
0.0 | 0.0 | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
52.02 % | -0.13 % | 36.03 % |
|
5yr average Equity Multiplier
|
4.62 | 2.16 | 1.79 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 0.95 | 0.77 |
|
5yr Avg Net Profit Margin
|
24.38 % | 0.03 % | 19.19 % |
|
Price to Book
|
10.8 | 10.99 | 14.48 |
|
P/E
|
22.48 | 212.62 | 29.24 |
|
5yr Avg Cash Conversion Cycle
|
4.83 Days | 49.09 Days | -155.74 Days |
|
Inventory Days
|
66.8 Days | 80.25 Days | 36.01 Days |
|
Days Receivable
|
31.98 Days | 79.76 Days | 40.92 Days |
|
Days Payable
|
63.37 Days | 114.46 Days | 215.28 Days |
|
5yr Average Interest Coverage Ratio
|
906.11 | 1.93 | 500.05 |
|
5yr Avg ROCE
|
27.19 % | 6.67 % | 30.21 % |
|
5yr Avg Operating Profit Margin
|
24.71 % | 7.74 % | 27.53 % |
|
5 yr average Debt to Equity
|
0.0 | 0.53 | 0.0 |
|
5yr CAGR Net Profit
|
31.63 % | -25.52 % | 4.02 % |
|
5yr Average Return on Assets
|
11.5 % | 0.05 % | 15.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
60.4 % | 61.41 % | 51.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 8.62 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.06 % | 5.57 % | 3.2 % |
|
Sanofi India
|
Viyash Scientific
|
Procter&Gamble Healt
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|